Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm Clinical Study of Carbon Ion Radiotherapy Combined with Nituzumab and Gemcitabine for Pancreatic Cancer.

NCT06840067 is registered in ClinicalTrials.gov with Gansu Wuwei Tumor Hospital as lead sponsor.

NCT NCT06840067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06840067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm Clinical Study of Carbon Ion Radiotherapy Combined with Nituzumab and Gemcitabine for Pancreatic Cancer.
Lead sponsor
Gansu Wuwei Tumor Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2025
Completion date
December 31, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer metastatic, pancreatic cancer non-resectable